These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
750 related articles for article (PubMed ID: 31616443)
1. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment. Li X; Xiang Y; Li F; Yin C; Li B; Ke X Front Immunol; 2019; 10():2293. PubMed ID: 31616443 [TBL] [Abstract][Full Text] [Related]
3. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers. Luke JJ; Bao R; Sweis RF; Spranger S; Gajewski TF Clin Cancer Res; 2019 May; 25(10):3074-3083. PubMed ID: 30635339 [TBL] [Abstract][Full Text] [Related]
4. Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy. Wang B; Tian T; Kalland KH; Ke X; Qu Y Trends Pharmacol Sci; 2018 Jul; 39(7):648-658. PubMed ID: 29678298 [TBL] [Abstract][Full Text] [Related]
5. Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment. Gajewski TF; Corrales L; Williams J; Horton B; Sivan A; Spranger S Adv Exp Med Biol; 2017; 1036():19-31. PubMed ID: 29275462 [TBL] [Abstract][Full Text] [Related]
6. Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response. Garris CS; Luke JJ Clin Cancer Res; 2020 Aug; 26(15):3901-3907. PubMed ID: 32332013 [TBL] [Abstract][Full Text] [Related]
7. Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity. Suryawanshi A; Hussein MS; Prasad PD; Manicassamy S Front Immunol; 2020; 11():122. PubMed ID: 32132993 [TBL] [Abstract][Full Text] [Related]
8. Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy. Wall JA; Meza-Perez S; Scalise CB; Katre A; Londoño AI; Turbitt WJ; Randall T; Norian LA; Arend RC Gynecol Oncol; 2021 Jan; 160(1):285-294. PubMed ID: 33168307 [TBL] [Abstract][Full Text] [Related]
9. Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types. Bao R; Stapor D; Luke JJ Genome Med; 2020 Oct; 12(1):90. PubMed ID: 33106165 [TBL] [Abstract][Full Text] [Related]
10. Wnt signaling pathway in cancer immunotherapy. Zhou Y; Xu J; Luo H; Meng X; Chen M; Zhu D Cancer Lett; 2022 Jan; 525():84-96. PubMed ID: 34740608 [TBL] [Abstract][Full Text] [Related]
11. Immune suppression and resistance mediated by constitutive activation of Wnt/β-catenin signaling in human melanoma cells. Yaguchi T; Goto Y; Kido K; Mochimaru H; Sakurai T; Tsukamoto N; Kudo-Saito C; Fujita T; Sumimoto H; Kawakami Y J Immunol; 2012 Sep; 189(5):2110-7. PubMed ID: 22815287 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody. Katoh Y; Yaguchi T; Kubo A; Iwata T; Morii K; Kato D; Ohta S; Satomi R; Yamamoto Y; Oyamada Y; Ouchi K; Takahashi S; Ishioka C; Matoba R; Suematsu M; Kawakami Y J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793868 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment. Spranger S Int Immunol; 2016 Aug; 28(8):383-91. PubMed ID: 26989092 [TBL] [Abstract][Full Text] [Related]
15. Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer. Sweis RF; Spranger S; Bao R; Paner GP; Stadler WM; Steinberg G; Gajewski TF Cancer Immunol Res; 2016 Jul; 4(7):563-8. PubMed ID: 27197067 [TBL] [Abstract][Full Text] [Related]
16. Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients. Massi D; Romano E; Rulli E; Merelli B; Nassini R; De Logu F; Bieche I; Baroni G; Cattaneo L; Xue G; Mandalà M Eur J Cancer; 2017 Jun; 78():70-81. PubMed ID: 28412591 [TBL] [Abstract][Full Text] [Related]
17. Blockade of β-Catenin-Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration. Ji L; Qian W; Gui L; Ji Z; Yin P; Lin GN; Wang Y; Ma B; Gao WQ Cancer Res; 2020 May; 80(10):2004-2016. PubMed ID: 32156780 [TBL] [Abstract][Full Text] [Related]